Prader-Willi syndrome (PWS) is commonly caused by the absence of a paternal contribution for imprinted genes in chromosome 15ql 1, either through a deletion in the paternal chromosome 1 5ql 1 or through the presence of two maternal chromosomes 15, a condition called maternal uniparental disomy (UPD).' 2 One mechanism leading to maternal UPD for chromosome 15 (UPD15 mat) is the rescue of a trisomic embryo, with two maternal chromosomes 15 , through the loss of the paternal chromosome 15. Several patients with PWS and mosaicism for trisomy 15 have been documented. 37 The same mechanism has also been described for UPD involving other chromosomes, for example, in UPD2 mat, UPD9 mat, UPD1 1pat, and UPD16 mat.8"' The finding of maternal heterodisomy for chromosome 15 in the majority of UPD 15 mat cases, '2 as well as a correlation with advanced maternal age,'3 1 provide additional indirect evidence to support trisomy rescue as a mechanism leading to UPD in PWS.
We present a patient with features of PWS who has mosaicism for trisomy 15 and for triplo-X, present in different cell lines. This is the first patient with trisomy 15 surviving beyond infancy on whom clinical follow up is provided. Molecular studies were undertaken to trace the events that led to this complex chromosomal aberration.
Case report This girl is the first child of healthy, unrelated parents. The mother has five older, healthy children from two previous marriages. At the time of delivery, the mother was 42 years and the father 40 gmol/l dNTPs, 0.5 gmol/l each primer, and 1 U Taq polymerase (Perkin-Elmer). Cycling conditions were: one minute at 94°C, one minute at 550C, and one minute at 720C. All PCR products were electrophoresed on an ALF DNA sequencer (Pharmacia Biotech) and analysed using Fragment Manager software (Pharmacia Biotech). Using the described PCR conditions, the signal intensities could be interpreted in terms of number and dose of alleles.
X inactivation was measured by Southern blot analysis of a methylation sensitive RFLP at the PGK locus.'9 Twelve ig of genomic DNA was digested with PstI and BstXI, after which the mixture was divided into two: one sample was digested further with HpaII and the other was not. Both samples were loaded onto 0.8% the ageof 3.3 agarose in adjacent lanes, blotted, and the filter n, and was hybridised with the pSPT/PGK probe, as sity. (B) Detail described. Figure 2 Analysis ofpolymorphic microsatellite markers on chromosome 15. The polymorphic microsatellite markers FES and Dl 5S107 were analysed in the patient (white blood cells and skin fibroblasts) and in the white blood cells of the mother andfather. In white blood cells of the patient, two different maternal alleles were present for marker D5SI 07, indicating the presence of uniparental heterodisomy for chromosome 15. The mother and patient were homozygous for the FES allele. In skin fibroblasts, an additional paternal allele is found at a lower dose compared to the maternal alleles (arrow), which is in accordance with the finding of trisomy 15 in approximately half of the cells. Figure 4 X inactivation analysis by Southern blot of the PGKgene. DNA from from the father (F), mother (M), and patient (P) was digested with PstI and BstM in lanes 2, 4, and 6 was further digested with the methylation sensitive restriction e HpaII. The father is hemizygous for the 0.9 kb allele, the mother homozygous for t kb allele. After HpaII digestion, the 0.9 kb allele completely disappeared in the fat) expected for an unmethylated, active X chromosome. In the patient, X chromosome inactivation is not abnormal, with either the maternal or paternal X chromosomes undergoing X inactivation in a fraction of cells. Dosage analysis by densitometry si that the dose of inactivated (methylated) X chromosomes (lane 6) versus the dose three X chromosomes (lane 5) was 213. Therefore, only a single active X chromoso; present in each cell, with the remaining two being inactivated. and the remaining two are inactivated. tivation is therefore random.
Discussion
The clinicial features in the present pa the diagnosis of PWS according to the of Holm et al.2' UPD15 mat was sh WBC, both by means of methylation an the PWS critical region and by micro, analysis, consistent with this diagnosis ever, her phenotype was atypical, as the,, of, for instance, the mental and retardation and feeding difficulties war more pronounced. Also, additional f not commonly observed in PWS were r including a heart defect, facial dysmoi and vesicoureteral reflux. These features attributed to the presence of a mosaic 15, found in 50% of the skin fibroblasts. few liveborn patients with mosaic trisc have been reported and most die e infancy, but nevertheless a specific phe is emerging, as reviewed by Milunsky The most consistent findings are hypotonia with feeding difficulties, craniofacial dysmorphism, mild anomalies, and congenital heart disease severe hypotonia could possibly be atti to the concomitant UPD 15 mat, bui cases need to be studied to delinea phenotype of trisomy 15 mosaicism. ' The presence of the triplo-X cell line in all 'runcal lymphocytes analysed as well as in fibroblasts t at the suggests a correction occurring early during r PWS embryonic development, before tissue differenined by tiation. X chromosome inactivation analysis iich is showed that only a single X chromosome is notype. active in the WBC, the other two being inacticould vated. Also, the WBC had a different X inactivation pattern and involved either one of the mat in two maternal and the paternal X chromo-:risomy somes. Since the cells with the triplo-X must be osome clonal in origin, the normal X inactivation seen rith tri-in the present patient can only be explained kers on when X inactivation came after the error leaday was ing to the triplo-X. Normal X inactivation group.bmj.com on July 5, 2017 -Published by http://jmg.bmj.com/ Downloaded from occurs after counting of the X chromosomes early in embryonic development.20 Thus, we provide evidence that the error leading to the triplo-X in this patient occurred before counting of the X chromosomes. Also, abnormal X inactivation does not play a part in the severity of the phenotype of the present child.
In conclusion, the errors leading to the two aneuploidies have occurred in a different cell division, one meiotic and the other postzygotic, and are therefore unrelated. A third error, the loss of a paternal chromosome 15, has also occurred postzygotically. This raises the possibility that both postzygotic errors, trisomy 15 recue and gain of an X chromosome, are related and might have occurred at the same cell division. If not, in order to explain the observed mosaicism, they certainly must have occurred shortly after each other. It is not possible to distinguish between these possibilities, and more cases need to be studied to answer this question. The further study of all these patients will therefore be particularly interesting.
